Bioventus (BVS) Earnings Date
The next earnings date for Bioventus (BVS) is around Mar 4, 2027, estimated from its own calendar.
- Next earnings date
- Around Mar 4, 2027
- estimated from its own calendar · quarter ending Dec '26
- Latest stored quarter
- EPS 0.08
- revenue $142.4M · reported Nov 2, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
1 of 2 scored quarters beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 2, 20268-K, after close · 4:05 pm ET | 0.15 | 0.08 | −46.5% | $149.5M | $142.4M | −4.7% | −16.8%next session |
| Aug 5, 20268-K, before open · 7:40 am ET | 0.22 | 0.47 | +117.3% | $155.4M | $153.2M | −1.4% | +13.7%release day |
| May 6, 20268-K, before open · 7:46 am ET | — | 0.04 | — | — | $132.1M | — | +2.2%release day |
| Mar 5, 20268-K, before open · 7:34 am ET | — | 0.21 | — | — | $157.9M | — | +7.4%release day |
| Nov 4, 20258-K, before open · 7:37 am ET | — | 0.05 | — | — | $138.7M | — | +15.1%release day |
| Aug 6, 20258-K, before open · 7:42 am ET | — | 0.11 | — | — | $147.7M | — | +18.7%release day |
| May 6, 20258-K, before open · 7:36 am ET | — | −0.04 | — | — | $123.9M | — | −11.8%release day |
| Mar 11, 20258-K, before open · 7:40 am ET | — | −0.01c | — | — | $153.6M | — | +23.3%release day |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 2 of the 8 quarters above carry a scored estimate. We never backfill an estimate we didn't observe.
c Computed by Tenet. The company's diluted figure is not in our data feed for this period, so this is net income attributable to common shareholders divided by the larger of the weighted basic and diluted share counts.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 3 | 2 | 4 | 4 |
| Avg estimate | 0.22 | 0.15 | 0.77 | 0.88 |
| Low estimate | 0.22 | 0.15 | 0.76 | 0.85 |
| High estimate | 0.23 | 0.16 | 0.78 | 0.90 |
| Year-ago EPS | 0.21 | 0.04 | 0.33 | 0.77E |
| Implied growth | +6.1% | +283.2% | +132.7% | +15.1% |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 3 | 2 | 4 | 4 |
| Avg estimate | $164.6M | $139.8M | $592.3M | $631.0M |
| Low estimate | $163.9M | $138.9M | $591.6M | $621.2M |
| High estimate | $165.3M | $141.4M | $593.0M | $640.9M |
| Year-ago revenue | $157.9M | $132.1M | $568.1M | $592.3ME |
| Implied growth | +4.2% | +5.8% | +4.3% | +6.5% |
| Snapshot age | Dec '26, period ending Dec 26, 2026 | Mar '27, period ending Mar 26, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | 0.22 | 0.15 | 0.77 | 0.88 |
| 7 days ago | 0.22 | 0.15 | 0.77 | 0.89 |
| 30 days ago | 0.24 | — | 0.78 | 0.92 |
| 60 days ago | 0.24 | — | 0.78 | 0.92 |
| 90 days ago | 0.25 | — | 0.78 | 0.92 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $0.25 → $0.22 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Bioventus report earnings next?
Bioventus' next earnings date is around Mar 4, 2027, estimated from its own calendar.
What were Bioventus' latest quarterly earnings?
Bioventus reported diluted EPS of 0.08 and revenue of $142.4M on Nov 2, 2026.
How did Bioventus' stock move after its last earnings report?
Bioventus moved −16.8% in the session after its Nov 2, 2026 report.

